In this episode, Tom, a cannabis lawyer, shares his predictions for cannabis legalization in 2026, focusing on three key areas: 1. When marijuana could be rescheduled to Schedule III and the tax benefits for businesses; 2. Potential changes to hemp laws that may impact the market; 3. The importance of CBD research and Medicare coverage. Tom provides a detailed analysis of the legislative and regulatory timelines, emphasizing the complexities and bureaucratic hurdles involved. He also highlights the significance of accurate data and research for the future of cannabis in healthcare.
We predict what’s next for cannabis legalization in 2026, focusing on potential marijuana rescheduling and how it impacts the industry. This episode also explores the “hemp fix” and the role of research and Medicare CBD, especially for cannabis for seniors. Stay informed on these critical cannabis news and market trends.
00:00 Introduction and 2026 Predictions Overview
00:28 Understanding Schedule Three and 280E
00:50 Debunking Common Misconceptions
01:37 Rescheduling Timeline and Industry Impact
02:43 Hemp Legislation and Enforcement
03:37 Congressional Actions and Deadlines
04:35 FDA’s Role and New Hemp Definitions
06:51 Executive Orders and Regulatory Framework
08:24 Shh… It’s a Secret Marijuana Rescheduling Chapter
12:58 Research and Medical Use of Cannabinoids
15:12 Predictions for 2026
16:34 Conclusion and Call to Action